Coenzyme Q, alpha tocopherol and delayed function in human kidney transplantation. 1990

F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
Department of Surgery, Catholic University, Policlinico Gemelli, Roma, Italy.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D009926 Organ Preservation The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Organ Preservations,Preservation, Organ,Preservations, Organ
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
September 1959, Archives of biochemistry and biophysics,
F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
October 2003, The Journal of nutrition,
F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
April 1996, Free radical research,
F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
October 1996, Bratislavske lekarske listy,
F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
August 2004, Experimental gerontology,
F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
July 1960, Anales de la Real Academia de Farmacia,
F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
January 2004, Lancet (London, England),
F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
February 2019, Current opinion in organ transplantation,
F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
October 1998, Journal of lipid research,
F Serino, and F Citterio, and S Lippa, and A Oradei, and S Agnes, and G Nanni, and A Pozzetto, and G Littarru, and M Castagneto
January 1986, International journal of tissue reactions,
Copied contents to your clipboard!